Artiva Biotherapeutics, Inc.
NASDAQARTV enters its August 7 earnings event having rallied 11% in one week and 23% in one month, yet a meaningful short position and uniformly bullish analyst coverage frame the debate about whether the clinical data can justify that move. Short sellers have been building through July. Short interest jumped roughly 40% over the past month to 7% of the free float — a level large enough…
ARTV short interest surges 249% in one week to 1.26% of float, highest spike since May began.
ARTV enters its August 7 earnings event having rallied 11% in one week and 23% in one month, yet a meaningful short position and uniformly bullish analyst coverage frame the debate about whether the clinical data can…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ARTV — free to start on ORTEX.
Sign up for free →Open ARTV on ORTEXSnapshot as of 20 Sept 2026
Pulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live ARTV data →